CC
CDMO

Centiva Capital’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Centiva Capital’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,892
Closed -$298K – 2087
2023
Q1 		$298K Buy
+15,892
New +$261K 0.01% 1059

Other funds holding CDMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.39B AUM 53.77% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Centiva Capital's CDMO Position: Q2 2023 in Review

Centiva Capital sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2023, closing a stake of 15,892 shares — an estimated $298K sold.

Centiva Capital first reported a position in CDMO in Q1 2023 and held it in 1 quarter. The position peaked at $298K in Q1 2023. 168 funds tracked by Wall St. Rank hold CDMO as of Q2 2023.

  • Centiva Capital reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Centiva Capital sold 15,892 Avid Bioservices, Inc. Common Stock shares in Q2 2023, an estimated $298K.
  • Centiva Capital first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Centiva Capital's Avid Bioservices, Inc. Common Stock position peaked at $298K in Q1 2023.
  • 168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2023.

Based on Centiva Capital's 13F filing for Q2 2023, filed 14 Aug 2023.